DiaMedica Therapeutics(DMAC)
MINNEAPOLIS, MNBiotechnology
Focus: DiaMedica Therapeutics is a public biotech company developing biologic therapeutics for neurology, nephrology, and metabolic diseases. The company is pre-revenue and focused on advancing a pipeline of recombinant protein and small molecule programs through early-stage clinical development.
Profile data last refreshed 21h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About DiaMedica Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow DiaMedica Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
7 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
DM199
Pre-EclampsiaClinical Trials (1)
NCT06875141DM199 for Pregnancy Complications
N/AHelp build intelligence for DiaMedica Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.